Volume 9, Issue 2, Pages (February 2004)

Slides:



Advertisements
Similar presentations
Volume 18, Issue 3, Pages (March 2010)
Advertisements

Volume 1, Issue 2, Pages (February 2000)
Volume 19, Issue 1, Pages (January 2011)
Volume 15, Issue 6, Pages (June 2007)
Volume 16, Issue 3, Pages (March 2008)
Volume 24, Issue 7, Pages (July 2016)
Volume 8, Issue 1, Pages (July 2003)
Generation of transgenic mice using lentiviral vectors: a novel preclinical assessment of lentiviral vectors for gene therapy  Masahito Ikawa, Nobushige.
Volume 24, Issue 7, Pages (July 2016)
Volume 25, Issue 3, Pages (March 2017)
Volume 12, Issue 4, Pages (October 2005)
Volume 7, Issue 6, Pages (June 2001)
Recent Developments in Retroviral-Mediated Gene Transduction
Volume 10, Issue 5, Pages (November 2004)
Volume 15, Issue 1, Pages (January 2007)
Volume 12, Issue 6, Pages (December 2005)
Volume 14, Issue 4, Pages (October 2006)
Generation of transgenic mice using lentiviral vectors: a novel preclinical assessment of lentiviral vectors for gene therapy  Masahito Ikawa, Nobushige.
Volume 11, Issue 6, Pages (June 2005)
Transient Gene Expression by Nonintegrating Lentiviral Vectors
Neeltje A Kootstra, Ryusuke Matsumura, Inder M Verma  Molecular Therapy 
Volume 6, Issue 2, Pages (August 2002)
Volume 10, Issue 1, Pages (July 2004)
Volume 12, Issue 6, Pages (December 2005)
Volume 12, Issue 3, Pages (September 2005)
Human Papilloma Virus E6 and E7 Proteins Support DNA Replication of Adenoviruses Deleted for the E1A and E1B Genes  Dirk S. Steinwaerder, Cheryl A. Carlson,
Molecular Therapy - Methods & Clinical Development
Volume 2, Issue 1, Pages (July 2000)
Expression of the MOZ-TIF2 oncoprotein in mice represses senescence
Volume 9, Issue 4, Pages (April 2004)
Volume 6, Issue 2, Pages (August 2002)
Lentiviral vectors containing mouse Csf1r control elements direct macrophage-restricted expression in multiple species of birds and mammals  Clare Pridans,
Volume 5, Issue 2, Pages (February 2002)
Transactivator and Structurally Optimized Inducible Lentiviral Vectors
Volume 11, Issue 4, Pages (April 2005)
Xiuwu Zhang, Chuan-Yuan Li  Molecular Therapy 
Generation of a stable packaging cell line producing high-titer PPT-deleted integration- deficient lentiviral vectors  Peirong Hu, Yedda Li, Mark S Sands,
Volume 15, Issue 9, Pages (September 2007)
Kailin Xu, Hong Ma, Thomas J. McCown, Inder M. Verma, Tal Kafri 
Development of an HIV-Based cDNA expression cloning system
Volume 12, Issue 5, Pages (November 2005)
Volume 12, Issue 5, Pages (November 2005)
Inclusion of jaagsiekte sheep retrovirus proviral elements markedly increases lentivirus vector pseudotyping efficiency  Patrick L. Sinn, Erin R. Burnight,
Volume 10, Issue 4, Pages (October 2004)
Volume 16, Issue 4, Pages (April 2008)
Volume 15, Issue 11, Pages (November 2007)
Volume 15, Issue 4, Pages (April 2007)
Generation and molecular characterization of LV producer cell lines
Volume 19, Issue 5, Pages (May 2011)
Production of lentiviral vectors
PiggyBac Transposon-mediated Gene Transfer in Human Cells
Volume 11, Issue 6, Pages (June 2005)
Volume 18, Issue 4, Pages (April 2010)
Volume 26, Issue 2, Pages (February 2018)
Cheryl A. Carlson, Dmitry M. Shayakhmetov, André Lieber 
Development of an HIV-Based cDNA expression cloning system
Changyu Zheng, Bruce J. Baum  Molecular Therapy 
Volume 15, Issue 9, Pages (September 2007)
Volume 10, Issue 6, Pages (December 2004)
Volume 2, Issue 4, Pages (October 2000)
Volume 19, Issue 1, Pages (January 2011)
High-level production of replication-defective human immunodeficiency type 1 virus vector particles using helper-dependent adenovirus vectors  Yani Hu,
Volume 7, Issue 3, Pages (March 2003)
Volume 21, Issue 3, Pages (March 2013)
Volume 9, Issue 4, Pages (April 2004)
Volume 11, Issue 5, Pages (May 2005)
Recent Developments in Retroviral-Mediated Gene Transduction
A Double-Switch Vector System Positively Regulates Transgene Expression by Endogenous microRNA Expression (miR-ON Vector)  Mario Amendola, Alice Giustacchini,
Volume 14, Issue 1, Pages (July 2006)
Volume 17, Issue 2, Pages (February 2009)
Presentation transcript:

Volume 9, Issue 2, Pages 209-217 (February 2004) Lentiviral Vectors Efficiently Transduce Quiescent Mature 3T3-L1 Adipocytes  Françoise Carlotti, Merlijn Bazuine, Tuija Kekarainen, Jurgen Seppen, Philippe Pognonec, J.Antonie Maassen, Rob C Hoeben  Molecular Therapy  Volume 9, Issue 2, Pages 209-217 (February 2004) DOI: 10.1016/j.ymthe.2003.11.021 Copyright © 2003 The American Society of Gene Therapy Terms and Conditions

Fig. 1 Transduction efficiency in 3T3-L1 adipocytes after adenovirus- and lentivirus-mediated gene transfer. Mature adipocytes were exposed (A) to adenoviral vectors containing a GFP reporter gene under the control of a CMV promoter at m.o.i. of 100, 400, or 1000 pfu/cell or (B) to lentiviral vectors containing GFP under a PGK promoter at 200 and 400 ng p24 per 105 cells. (C) Transductions were performed as a control with adenoviruses (top) at m.o.i. of 5 in HeLa cells (picture after 2 days) and with lentiviruses (bottom) at 40 ng p24 per 105 cells in 293T cells (picture after 3 days). m.o.i., multiplicity of infection. Two different magnifications were used in A and B (left and right). Molecular Therapy 2004 9, 209-217DOI: (10.1016/j.ymthe.2003.11.021) Copyright © 2003 The American Society of Gene Therapy Terms and Conditions

Fig. 2 Schematic representations of the lentivirus vectors. (A) The constructs are all derivatives of the third generation of HIV-1 lentivirus vectors. The top depicts various elements in the self-inactivating lentiviruses as described in the text. The enhancer region contained in the 3′ LTR is deleted. The internal promoter drives expression of the gene of interest (X). Also indicated are the positions of the Rev-responsive element (RRE), the central polypurine tract (cPPT), and the posttranscriptional regulatory element (PRE). The bottom depicts the structure of the integrated provirus and illustrates the single transcript (arrow) that is derived from it. (B) Schematic outline of the three helper plasmids that were used to produce the vector stocks. These plasmids provide the messengers encoding the gag–pol and the rev from HIV-1 and the envelope glycoproteins from the vesicular stomatitis virus (VSV-G). The promoters used in these constructs are derived from the human cytomegalovirus (CMV) and Rous sarcoma virus (RSV), the polyadenylation signals from simian virus 40 (SV40) and the human β-globin gene (hβG), as indicated. Molecular Therapy 2004 9, 209-217DOI: (10.1016/j.ymthe.2003.11.021) Copyright © 2003 The American Society of Gene Therapy Terms and Conditions

Fig. 3 Insulin-induced glucose uptake assay. 3T3-L1 mature adipocytes were exposed (A) to Ad-CMV-Luc at m.o.i. of 100, 400, or 1000 pfu/cell or (B) to LV-PGK-GFP at 80 ng p24 per 105 cells. Luciferase activity was measured as a control of the transduction efficiency with the adenovirus, and GFP expression was determined by microscopy to control for lentiviral transduction. Transduced cells were stimulated by insulin (100 nM) for 15 min and assayed for intracellular 2-deoxy-d-[14C]glucose (2-DOG) uptake. Values are means of three to six independent experiments and experiments were repeated at least two times. Values are given in pmol 2-DOG/min · mg protein. Molecular Therapy 2004 9, 209-217DOI: (10.1016/j.ymthe.2003.11.021) Copyright © 2003 The American Society of Gene Therapy Terms and Conditions

Fig. 4 Confocal microscopy of mature adipocytes transduced by lentiviruses. (A) 3T3-L1 mature adipocytes (B and C) were transduced by lentiviruses expressing a PGK-GFP cassette (120 ng p24 per 105 cells) and (D) stained by Nile red dye. (E) An overlay of GFP expression in the cytoplasm and the nucleus and Nile red staining specifically in the lipid droplets. Molecular Therapy 2004 9, 209-217DOI: (10.1016/j.ymthe.2003.11.021) Copyright © 2003 The American Society of Gene Therapy Terms and Conditions

Fig. 5 Comparison transfection/lentivirus transduction. (A) 3T3-L1 preadipocytes were transduced by CMV-GFP lentivirus at 20, 40, 80, or 200 ng p24 per 105 cells or transfected with 0.1, 0.25, 0.5, or 1 μg of pLV-CMV-GFP plasmid using JetPEI reagent. (B) 293T cells were infected in a similar way (4, 10, 20, 40, 80, or 200 ng p24 per 105 cells by lentiviruses) or transfected using the CaPO4 method with the same amounts of DNA. GFP-positive cells were determined by UV microscopy, and percentages were defined by FACS analysis after 3 days. Experiments were performed in 24-well-plates with 1 μg DNA/well in total. pLV-CMV-GFP plasmid was used, and adjustments to obtain equal amounts of DNA were done with pLV-CMV vector. Molecular Therapy 2004 9, 209-217DOI: (10.1016/j.ymthe.2003.11.021) Copyright © 2003 The American Society of Gene Therapy Terms and Conditions

Fig. 6 Detection of integrated provirus and stability of expression. (A) 3T3-L1 adipocytes were transduced by LV-CMV-GFP lentivirus (200 ng p24 per 105 cells) or mock transduced (0 ng p24 per 105 cells; top). Four days after transduction, genomic DNA was extracted as described and assayed using B2-nested PCR analysis as described under Materials and Methods. The bottom left corresponds to the PCR products from the B2-vector reaction (PCR 1), and the bottom right corresponds to the nested PCR (PCR 1 + 2) and the control reactions (PCR 2) with pLV-CMV-GFP plasmid (C+) and unamplified genomic DNA. (B) Transduced (40 ng p24 per 105 cells) or untransduced (Mock) 3T3-L1 preadipocytes were differentiated into mature adipocytes. Transduction efficiency was followed by UV microscopy after 4 days (Before Differentiation) and after 15 days of differentiation (After Differentiation). Molecular Therapy 2004 9, 209-217DOI: (10.1016/j.ymthe.2003.11.021) Copyright © 2003 The American Society of Gene Therapy Terms and Conditions